439 related articles for article (PubMed ID: 9200654)
1. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
[TBL] [Abstract][Full Text] [Related]
2. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
Diabetes; 1994 Sep; 43(9):1108-13. PubMed ID: 8070610
[TBL] [Abstract][Full Text] [Related]
3. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
[TBL] [Abstract][Full Text] [Related]
4. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
[TBL] [Abstract][Full Text] [Related]
5. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
[TBL] [Abstract][Full Text] [Related]
6. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
Bakris GL; Copley JB; Vicknair N; Sadler R; Leurgans S
Kidney Int; 1996 Nov; 50(5):1641-50. PubMed ID: 8914031
[TBL] [Abstract][Full Text] [Related]
8. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
Tarnow L; Sato A; Ali S; Rossing P; Nielsen FS; Parving HH
Diabetes Care; 1999 Mar; 22(3):491-4. PubMed ID: 10097934
[TBL] [Abstract][Full Text] [Related]
9. Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.
Schnack C; Hoffmann W; Hopmeier P; Schernthaner G
Diabetologia; 1996 Dec; 39(12):1611-6. PubMed ID: 8960851
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
Rossing K; Jacobsen P; Pietraszek L; Parving HH
Diabetes Care; 2003 Aug; 26(8):2268-74. PubMed ID: 12882847
[TBL] [Abstract][Full Text] [Related]
11. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
[TBL] [Abstract][Full Text] [Related]
12. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
[TBL] [Abstract][Full Text] [Related]
13. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.
Samuelsson O; Hedner T; Ljungman S; Herlitz H; Widgren B; Pennert K
Eur J Clin Pharmacol; 1992; 43(5):469-75. PubMed ID: 1336463
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
16. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
17. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.
Georgianos PI; Agarwal R
Clin J Am Soc Nephrol; 2015 Apr; 10(4):639-45. PubMed ID: 25784174
[TBL] [Abstract][Full Text] [Related]
18. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
[TBL] [Abstract][Full Text] [Related]
20. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
Rossing K; Christensen PK; Jensen BR; Parving HH
Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
